[Intralymphatic B.C.G. infusions. Preliminary results (40 cases)].
A new route of administration for BCG aimed at stimulating immunity in cancer patients is presented. 40 patients received an intra-lymphatic infusion of BCG and in 20 lymphnode dissection was carried out for bacteriological and histological study. Details of technique and the results are given with regard to the effects of BCG on pelvic and pre-vertebral nodes after injection via a foot vessel.
D001500:BCG Vaccine / Q000008:administration & dosage*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D005528:Foot; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology; D007167:Immunotherapy; D007272:Injections, Intralymphatic / Q000009:adverse effects; D008198:Lymph Nodes / Q000382:microbiology / Q000473:pathology; D008199:Lymphadenitis / Q000209:etiology; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010388:Pelvis; D012877:Skin Manifestations; D013131:Spine
D001500:BCG Vaccine
Les infusions intra-lymphatiques de B.C.G. Résultats préliminaires (40 cas)